Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. J. Curtis Nickel, Queen's University
ClinicalTrials.gov Identifier:
NCT00407329
First received: December 1, 2006
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)